FEATURE ARTICLE

ThromboGenics sets Jetrea
U.S. launch as Jan. 14

ThromboGenics NV (Euronext Brussels: THR), an integrated biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines, confirms its Jetrea U.S. launch date of January 14. » More

SPECIAL NEWS

Discover more about glaucoma

See the January issue of Optometry Times.
The Special Section features the latest developments in diagnosing and treating glaucoma.

TODAY'S HEADLINES

B + L licenses new technology for treating
ocular redness

Bausch + Lomb to license brimonidine for ocular redness treatment » More

During Glaucoma Awareness Month, emphasize
early diagnosis, treatment, AOA says

Look to early diagnosis and treatment for better glaucoma management, says American Optometric Association (AOA) during Glaucoma Awareness Month. » More

Together, we can TAKE on glaucoma

Direct your glaucoma patients to a new consumer-friendly Web site developed by the Glaucoma Foundation, the Alliance for Aging Research, and Merck (IOVS). » More

Alden Optical debuts on-demand online learning

Alden Optical launches Alden On-Demand series, with the first a NovaKone training and certification. » More

AOS files Chapter 11, will continue to represent interests of ODs

The American Optometric Society (AOS) has filed for Chapter 11 bankruptcy and confirms it will continue to operate. » More